⟵ Back to Search Results

BGB-A317-102

Completed

Study Investigating Safety, Tolerability, Pharmacokinetics (PK) and Antitumor Activities of Anti-PD-1(Programmed Death-1) Monoclonal Antibody

Beigene Study ID info

BGB-A317-102

ClinicalTrials.gov ID info

NCT04068519

Study Overview

Sex: All

Age: 18 Years and older (Adult, Older Adult)

Accepts Healthy Volunteers? yes

No Study Documents

Study Overview

Sex: All

Age: 18 Years and older (Adult, Older Adult)

Accepts Healthy Volunteers? yes

No Study Documents

You will be redirected to

Click the link above to continue or CANCEL